Primary Stroke Prevention Guidelines Pocket Guide - Guideline Central

Primary Stroke Prevention

American Heart Association, American Stroke AssociationPublished: February 4, 2025

A PDF version of this Pocket Guide is also available!
$15.95
  • Overview
    • Top 10 Take-Home Messages
  • General Concepts
  • Patient Assessment
  • Management
  • Risk Factors
    • Asymptomatic Carotid Artery Stenosis
    • Asymptomatic Cerebral SVD, Including Silent Cerebral Infarcts
    • Migraine
  • Specific Populations
    • Sickle Cell Disease
    • Genetic Stroke Syndromes
    • Coagulation and Inflammatory Disorders
    • Substance Use and Substance Disorders
    • Sex- and Gender-Specific Factors
  • Heart Disease
    • Cardiomyopathy
    • Antiplatelet Use for Primary Prevention
  • Tables
    • Study Populations and Characteristics Included for Primary Prevention Evidence Review
    • Key Conditions Affecting Stroke Risk and Screening Methods to Classify Them as Emphasized in This Guideline for Primary Prevention of Stroke
    • Summary of the Randomized Controlled Trial (RCT) Evidence for the Effects of Miscellaneous Dietary Interventions on Stroke Risk
    • Anthropometric Measures of Obesity and Associated Stroke Risk
    • Methods and Ranges of Diabetes Diagnosis
    • Qualifications for Treatment With Lipid Therapy
    • Mean Flow Velocity Timing Paradigms for TCD Reevaluation and Candidacy for Exchange Transfusion
    • Genetic Stroke Syndromes
    • Definitions of Medium to High aPL Titers and of High-Risk and Low-Risk aPL Profiles
    • Definitions and Diagnostic Thresholds for Hypertension in Pregnancy
    • APOs Associated With Long-Term Stroke Risk
    • Contraception Method and Effect on Stroke Risk
  • Figures and Algorithms
    • Elements Associated With Elevated Stroke Risk
    • Selected Genetic, Biological, and Social Factors Affecting Stroke Risk
    • Life’s Essential 8
    • Mechanisms of Pregnancy-Associated Stroke
    • Screening Algorithm for History of Adverse Pregnancy Outcomes in Adults
    • Considerations for Menopausal Hormone Treatment (MHT) to Minimize Stroke Risk


You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.